Can Semaglutide Affect Your Period?

Summary: Semaglutide is not directly listed on the FDA Ozempic or Wegovy labels as affecting menstrual cycles, but rapid weight loss, improved insulin sensitivity, and changes to oral contraceptive absorption can shift periods in ways that matter for both birth control and fertility planning.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: yes, indirectly. Semaglutide is not listed as a direct cause of menstrual changes anywhere on the FDA Ozempic or Wegovy labels ^[1][2]. The drug does not act on estrogen, progesterone, or any reproductive hormone. But it causes the kind of rapid weight loss that reliably shifts menstrual function, and for women with PCOS or insulin resistance it can re-start cycles that have been irregular for years. That same effect makes unplanned pregnancy a real risk on semaglutide, especially in the first few months.

Here is what is actually happening, why it varies so much between people, and what to do about it.

What the FDA label says (and does not say)

The Ozempic and Wegovy prescribing information lists nausea, vomiting, diarrhea, constipation, abdominal pain, pancreatitis warnings, gallbladder disease, kidney injury, and hypoglycemia (when combined with insulin or sulfonylureas) as the main adverse events ^[1][2]. Menstrual irregularity, amenorrhea, heavy bleeding, and dysmenorrhea are not in the adverse reactions table for either drug. The clinical trials that supported approval (SUSTAIN for Ozempic, STEP for Wegovy) did not flag a menstrual signal.

That matters because the question "does semaglutide directly disrupt your hormones" has a clear answer: no documented direct effect. The question "can being on semaglutide change your cycle" has a different answer: yes, through several indirect mechanisms.

The weight-cycle connection

Body fat is endocrine tissue. Adipocytes synthesize estrogen, and they convert androgens to estrogen through the aromatase enzyme. When body fat changes quickly in either direction, circulating estrogen levels shift, and the hypothalamic-pituitary-ovarian axis adjusts.

For women in the overweight or obese range, sustained weight loss typically moves cycles toward normal. Excess adipose tissue produces extra estrogen, which can suppress follicle-stimulating hormone signaling and either skip ovulation or produce a thick, unstable uterine lining that sheds unpredictably. Drop 10 to 15 percent of body weight on semaglutide and that pattern often resolves. Periods become more regular, lighter, and more predictable. Ovulation, which may have been absent or sporadic, returns.

For women already at a healthy weight, or for those losing weight very fast, the swing goes the other way. The body reads aggressive caloric deficit as a stress signal and downregulates reproductive function. Cycles lengthen, periods get lighter or skip entirely, and ovulation may pause. This is the same functional hypothalamic amenorrhea pattern seen in endurance athletes and people in eating disorder recovery. It is not unique to GLP-1 drugs; it is the metabolic response to rapid energy loss.

The practical takeaway: a woman starting semaglutide at a BMI of 35 is likely to see her cycle become more regular over six months. A woman starting at a BMI of 24 who loses 20 pounds in three months is more likely to see cycles lengthen or skip.

PCOS specifically

Polycystic ovary syndrome is the case where semaglutide's effect on periods is the clearest and the most clinically meaningful. PCOS combines hyperandrogenism, ovulatory dysfunction, and (in most cases) insulin resistance. The insulin resistance drives elevated androgens, which suppress ovulation, which produces irregular or absent periods. Treating the insulin resistance frequently restores cycles even before significant weight change.

GLP-1 receptor agonists improve insulin sensitivity through both weight-dependent and weight-independent mechanisms. In a study by Jensterle and colleagues, semaglutide produced significant reductions in body weight, fat mass, and metabolic markers in women with obesity and PCOS ^[3]. Patients in similar trials and case series have reported restored menses within two to four months of starting semaglutide, with ovulation confirmed by mid-luteal progesterone or basal body temperature tracking.

If your PCOS has kept your cycles irregular for years and you start semaglutide, expect change. You may ovulate for the first time in a long time. Your bleeding pattern may shift dramatically in the first three to six months as the endometrium thins from a less estrogen-dominant baseline. Heavier withdrawal bleeds early on, followed by lighter and more regular cycles, is a common pattern.

The fertility implication that catches people off guard

This is the most under-communicated consequence of semaglutide in women of reproductive age: if your cycles become more regular and you start ovulating reliably, you are more fertile than you were before treatment. Women who had been told for years they had "trouble conceiving" because of PCOS or obesity-related anovulation can become pregnant within a few cycles of starting a GLP-1.

That is good news if pregnancy is the goal. It is a problem if it is not.

The Ozempic label carries similar pregnancy guidance: stop the drug if pregnancy occurs, and weigh risks against benefits when restarting after delivery ^[1]. Breastfeeding data is limited; the drug has not been adequately studied in lactation, and most prescribers recommend pausing during nursing.

If you are actively trying to conceive, talk to your obstetrician about timing the discontinuation. Two months pre-conception is the Wegovy guidance; some specialists extend that to allow for full metabolic stabilization before pregnancy, especially in PCOS patients where pre-pregnancy weight and glucose status influence outcomes ^[4].

Oral contraceptive interactions

Semaglutide slows gastric emptying. That is part of how it suppresses appetite. Slower stomach emptying theoretically reduces the rate at which oral medications dissolve and absorb, including combined oral contraceptives.

The clinical data on this is limited. Novo Nordisk's pharmacokinetic studies for oral semaglutide (Rybelsus) showed no meaningful change in ethinyl estradiol or levonorgestrel exposure when co-administered. Studies on injectable semaglutide and combined oral contraceptives are sparser, and the question is partly inferential rather than directly tested. The FDA labels do not flag oral contraceptive failure as a documented interaction ^[1][2].

That said, some clinicians take a precautionary stance, particularly in the first few months when gastric emptying delay is most pronounced and when GI side effects (vomiting, severe nausea) can reduce pill absorption directly. The pragmatic approach:

• If you are on a combined oral contraceptive and using semaglutide, your pill is probably still effective in most cases.
• If you are vomiting within two hours of taking your pill, treat that as a missed dose per your pill's package insert.
• If you want maximum certainty, switch to or add a non-oral contraceptive method (IUD, implant, injection, ring, or patch) during semaglutide treatment, especially in the first three months and during dose escalations ^[5].
• Condoms as a backup during the titration period are a reasonable conservative move.

This is a topic where the risk-benefit is highly individual. Talk to your prescriber or OB-GYN about which method fits your situation.

What people actually report on semaglutide

Pulled from patient reports and the menstrual-disorder literature, the most common cycle changes on semaglutide are:

None of these is unique to semaglutide. All are well-documented consequences of weight loss and insulin sensitization in general. The pattern you experience depends on your starting weight, your rate of loss, your underlying reproductive baseline, and your age.

What about yeast infections and other GU symptoms

The FDA labels for Ozempic and Wegovy do not list vulvovaginal candidiasis as a known adverse reaction ^[1][2]. The mechanism people sometimes cite (high glucose feeding yeast growth) applies more to SGLT2 inhibitors like empagliflozin, which spill glucose into the urine and do show a documented yeast infection signal. GLP-1 receptor agonists lower blood glucose without urinary glucose excretion, so the mechanism does not transfer.

That said, dehydration from GI side effects, antibiotic use for other reasons, and hormonal shifts during rapid weight loss can all independently raise yeast infection risk. If you develop recurrent vulvovaginal symptoms while on semaglutide, it is unlikely to be a direct drug effect, but worth a workup with your clinician.

What to do if your period changes on semaglutide

A simple practical playbook:

1. Track every cycle from day one of semaglutide. Date of first day of bleeding, flow heaviness, duration, any spotting. A free app or a paper calendar works equally well. Without a baseline you cannot tell what changed.
2. Decide on contraception before the first injection, not after. If you do not want to be pregnant, use a non-pill method or use condoms as backup. Restored fertility in PCOS or obesity-related anovulation can show up within weeks.
3. If you skip more than two consecutive periods, take a pregnancy test. Then call your OB-GYN. Hypothalamic suppression from rapid loss is the most likely explanation in a thin patient, but pregnancy needs to be ruled out first.
4. If bleeding is heavier than normal, lasts more than seven days, or includes large clots, contact your gynecologist. Anemia from sustained heavy flow is preventable if you catch it early. Not all heavy bleeding on semaglutide is benign endometrial adjustment; some patients have unrelated fibroids or polyps that became symptomatic for other reasons.
5. If you are trying to conceive, plan the discontinuation with your doctor. Wegovy's label says 2 months before pregnancy ^[2]. Some specialists prefer longer for full metabolic stabilization.
6. If you are postpartum, do not restart semaglutide without checking on breastfeeding status. Lactation safety data is limited and most prescribers wait until weaning.

Common questions about semaglutide and menstrual cycles

Does Ozempic affect your menstrual cycle?

Indirectly, yes. Ozempic is not FDA-labeled as causing menstrual changes, but the weight loss and improved insulin sensitivity it produces frequently shift cycle length, flow, and ovulation regularity.

Does Wegovy affect your period?

Wegovy can affect periods through the same mechanisms as Ozempic (it is semaglutide at higher doses for weight loss). Cycle changes are common, especially in the first 3 to 6 months as weight drops rapidly.

Can semaglutide cause a missed period?

Yes. Rapid weight loss can suppress hypothalamic GnRH signaling and skip ovulation. If you miss more than two consecutive periods, take a pregnancy test and call your gynecologist.

Can semaglutide cause heavier periods?

It can, particularly in higher-BMI patients early in treatment. Falling estrogen production from shrinking adipose tissue can produce heavier withdrawal bleeds before cycles stabilize.

Does semaglutide help with PCOS-related irregular periods?

Often, yes. By improving insulin sensitivity and reducing weight, semaglutide restores ovulation in many PCOS patients. It is not FDA-approved for PCOS but is widely used off-label.

Can you get pregnant on semaglutide?

Yes, and more easily than before if your baseline included PCOS or weight-related anovulation. The Wegovy label instructs stopping the drug at least 2 months before planned pregnancy and immediately if pregnancy occurs.

Does semaglutide reduce the effectiveness of birth control pills?

The FDA labels do not list oral contraceptives as a documented interaction. Theoretical concerns exist because of slowed gastric emptying. Many clinicians recommend a non-oral method or condom backup during the first 3 months and dose escalations.

Is it safe to take semaglutide while breastfeeding?

Lactation safety data is limited and the FDA labels do not establish breastfeeding safety. Most prescribers pause semaglutide during nursing. Talk to your OB-GYN before continuing or restarting.

When can I restart semaglutide after pregnancy?

After delivery and (if applicable) after weaning, with your obstetrician's input. There is no fixed timeline on the label, but most clinicians wait until breastfeeding ends and your metabolic baseline is stable.

Can semaglutide cause yeast infections?

The FDA labels for Ozempic and Wegovy do not list yeast infections as a documented adverse reaction. GLP-1 drugs do not spill glucose into urine the way SGLT2 inhibitors do, so the standard mechanism does not apply.

Should I stop semaglutide if my period changes?

Not automatically. Cycle changes on GLP-1 drugs are common and often resolve as weight stabilizes. Track the pattern, take a pregnancy test if you skip periods, and talk to your OB-GYN about whether the changes warrant evaluation.

Bottom line

Semaglutide does not directly target reproductive hormones, and the FDA labels do not list menstrual changes as a known adverse reaction. But the drug works by producing rapid weight loss and improving insulin sensitivity, and both of those reliably move menstrual function. Direction depends on your starting point: lighter and more regular if you started in PCOS or obesity territory, or lighter and less frequent if you started lean and lost fast.

The most important practical point is the fertility one. If semaglutide restores your ovulation and you are not using reliable contraception, pregnancy can happen quickly, and semaglutide is contraindicated during pregnancy. Decide on a birth control plan with your OB-GYN before the first injection, not after the cycle changes show up.